Clinical Trials List
2021-10-01 - 2028-07-07
Phase III
Recruiting8
ICD-10N00.0
Acute nephritic syndrome with minor glomerular abnormality
ICD-10N00.1
Acute nephritic syndrome with focal and segmental glomerular lesions
ICD-10N00.2
Acute nephritic syndrome with diffuse membranous glomerulonephritis
ICD-10N00.3
Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
ICD-10N00.4
Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
ICD-10N00.5
Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
ICD-10N00.6
Acute nephritic syndrome with dense deposit disease
ICD-10N00.7
Acute nephritic syndrome with diffuse crescentic glomerulonephritis
ICD-9580.0
Acute glomerulonephritis, with lesion of proliferative glomerulonephritis
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chang-Youh Tsai Division of Rheumatology
- Chien-Chih Lai 風濕免疫科
- Yi-Syuan Sun 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shue-Fen Lo Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
- 張哲慈 Division of Rheumatology
- Yao-Fan Fang Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Hsing Chen Division of Rheumatology
- 譚國棟 Division of Rheumatology
- 廖育婉 Division of Rheumatology
- 許鶴忀 Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- HSIN-HUA CHEN Division of Rheumatology
- 陳彥如 Division of Rheumatology
- 謝祖怡 無
- 謝佳偉 Division of Rheumatology
- 吳沂達 Division of Rheumatology
- 林靖才 Division of Rheumatology
- 洪維廷 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃建中 風濕免疫科
- Po-Hao Huang 風濕免疫科
- Chen Der-Yuan 風濕免疫科
- 張詩欣 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
360 participants